8.
Prognostic factors | Univariate | Multivariate | |||||
HR | 95% CI | P | HR | 95% CI | P | ||
OS, overall survival; AC/ASC, adenocarcinoma/adenosquamous carcinoma; BMI, body mass index; FIGO, International Federation of Gynecology and Obstetrics; LNM, lymph node metastasis; LVSI, lymphovascular space invasion; HR, hazard ratio; 95% CI, 95% confidence interval. | |||||||
Age at diagnosis (year) (≥45 vs. <45) | 1.106 | 0.276–4.425 | 0.887 | – | – | – | |
BMI (kg/m2) (≥24 vs. <24) | 0.988 | 0.247–3.951 | 0.986 | – | – | – | |
FIGO stage (Ib vs. IIa) | 1.763 | 0.354–8.777 | 0.483 | – | – | – | |
Tumor size (cm) (≤4 vs.>4) | 0.297 | 0.070–1.258 | 0.081 | – | – | – | |
Differentiation (G1–G2 vs. G3) | 0.100 | 0.012–0.817 | 0.008 | 0.107 | 0.013–0.871 | 0.037 | |
LNM (+ vs. –) | 4.113 | 1.024–16.525 | 0.031 | 3.716 | 0.926–14.908 | 0.064 | |
Stromal invasion (≥1/2 vs. <1/2) | 0.343 | 0.042–2.797 | 0.295 | – | – | – | |
LVSI (+ vs. –) | 4.640 | 1.160–18.564 | 0.017 | 2.361 | 0.546–10.217 | 0.240 |